EUA
SelfCheck cobas SARS-CoV-2 + Flu Assay
FDA Emergency Use Authorization · Cleveland Clinic Robert J. Tomsich Pathology and Laboratory Medicine Institute · Aug 17, 2022
Key facts
| Product | SelfCheck cobas SARS-CoV-2 + Flu Assay |
|---|---|
| Company | Cleveland Clinic Robert J. Tomsich Pathology and Laboratory Medicine Institute |
| Product type | Real-time RT-PCR, Home Collection, Multi-analyte, Multiple Targets |
| Date | Aug 17, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: